Skip to main content
. Author manuscript; available in PMC: 2015 Nov 23.
Published in final edited form as: Brain (Bacau). 2014 Dec;5(1-4):16–25.

Figure 3.

Figure 3

Resulting comparisons isolating the Dopamine D2 Mesolimbic Pathway using statistical non-Paramentric Mapping (SnPM) indicating statically significant (p<0.05), via unpaired t-tests, results of 100 Schizophrenia patients medicated with Atypical Antipsychotics (ATAPs) compared with 32 Depressive patients medicated with Selective Serotonin Reuptake Inhibitors (SSRIs). *Indicates the non-statistically significant findings. ***Indicates the group SnPM pathway with statistically significant p<0.05 findings.